Wesley Scott Harper, Alameda, CA (US); Annie C. Tan, Redwood City, CA (US); Timothy Christian Dunn, San Francisco, CA (US); Mark Kent Sloan, Redwood City, CA (US); Kenneth J. Doniger, Menlo Park, CA (US); Michael Love, Pleasanton, CA (US); Phillip Yee, San Francisco, CA (US); Gary Alan Hayter, Oakland, CA (US); R. Curtis Jennewine, Portland, OR (US); and Glenn Howard Berman, Alameda, CA (US)
Assigned to ABBOTT DIABETES CARE INC., Alameda, CA (US)
Filed by ABBOTT DIABETES CARE INC., Alameda, CA (US)
Filed on Apr. 14, 2022, as Appl. No. 17/720,986.
Application 17/720,986 is a continuation of application No. 17/580,593, filed on Jan. 20, 2022.
Application 17/580,593 is a continuation of application No. 17/107,097, filed on Nov. 30, 2020, granted, now 11,241,175, issued on Feb. 8, 2022.
Application 17/107,097 is a continuation of application No. 17/067,443, filed on Oct. 9, 2020, granted, now 10,918,342, issued on Feb. 16, 2021.
Application 17/067,443 is a continuation of application No. 16/902,111, filed on Jun. 15, 2020, granted, now 10,881,355, issued on Jan. 5, 2021.
Application 16/902,111 is a continuation of application No. 16/664,083, filed on Oct. 25, 2019, granted, now 10,772,572, issued on Sep. 15, 2020.
Application 16/664,083 is a continuation of application No. 16/181,081, filed on Nov. 5, 2018, granted, now 10,456,091, issued on Oct. 29, 2019.
Application 16/181,081 is a continuation of application No. 15/808,918, filed on Nov. 10, 2017, granted, now 10,123,752, issued on Nov. 13, 2018.
Application 15/808,918 is a continuation of application No. 15/377,989, filed on Dec. 13, 2016, granted, now 9,814,416, issued on Nov. 14, 2017.
Application 15/377,989 is a continuation of application No. 14/938,840, filed on Nov. 11, 2015, granted, now 9,549,694, issued on Jan. 24, 2017.
Application 14/938,840 is a continuation of application No. 14/457,066, filed on Aug. 11, 2014, granted, now 9,186,113, issued on Nov. 17, 2015.
Application 14/457,066 is a continuation of application No. 13/970,556, filed on Aug. 19, 2013, granted, now 8,816,862, issued on Aug. 26, 2014.
Application 13/970,556 is a continuation of application No. 12/871,901, filed on Aug. 30, 2010, granted, now 8,514,086, issued on Aug. 20, 2013.
Claims priority of provisional application 61/297,625, filed on Jan. 22, 2010.
Claims priority of provisional application 61/247,541, filed on Sep. 30, 2009.
Claims priority of provisional application 61/238,672, filed on Aug. 31, 2009.
Claims priority of provisional application 61/238,657, filed on Aug. 31, 2009.
Prior Publication US 2022/0233111 A1, Jul. 28, 2022
1. A non-transitory computer-readable medium comprising instructions which, when executed by processing circuitry, are configured to cause the processing circuitry to:
receive processed glucose data indicative of monitored glucose levels from a transcutaneous glucose sensor positioned at least in part in contact with interstitial fluid in a body of a user;
detect a high glucose condition associated with the processed glucose data;
suppress output of an alarm through a user interface for a predetermined wait period following detecting the high glucose condition, wherein the predetermined wait period is user-selectable;
detect that the high glucose condition still exists after expiry of the predetermined wait period; and
output the alarm based on the detected high glucose condition still existing.
